Increased BMI is associated with significantly larger MI risk reduction with GLP-1RA, implying that weight reduction may further reduce residual ASCVD risk with GLP-1RA use
*Correspondence: Isabelle Boileau, [email protected] These authors have contributed equally to this work This article was submitted to Neuroimaging, a section of the journal Frontiers in Psychiatry Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Glutathione (reduced glutathione, GSH) endogenous antioxidant molecule
Methods We conducted a descriptive, retrospective analysis of electronic medical records from LUX MED [7, 8], a major private healthcare provider in Poland, spanning January 1, 2018, to December 31, 2024
But lets cut through the hype and focus on whats real, safe, and evidence-based